Gender survival differences in hepatocellular carcinoma: Is it all due to adherence to surveillance? A study of 1716 patients over three decades

por Liou, Wei‐Lun, Tan, Terence J‐Y., Chen, Kaina, Goh, George B‐B., Chang, Jason P‐E., Tan, Chee‐Kiat
Publicado 2023

Perceptions of non-alcoholic fatty liver disease – an Asian community-based study

por Goh, George B.B., Kwan, Clarence, Lim, Sze Ying, Venkatanarasimha, Nanda KK, Abu-Bakar, Rafidah, Krishnamoorthy, Thinesh L, Shim, Hang Hock, Tay, Kiang Hiong, Chow, Wan Cheng
Publicado 2016

N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing

por Keng, Bryan M. H., Gao, Fei, Tan, Ru San, Ewe, See Hooi, Teo, Louis L. Y., Xie, Bei Qi, Goh, George B. B., Koh, Woon-Puay, Koh, Angela S.
Publicado 2018

A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decade

por Lim, Miao‐Shan, Goh, George B‐B, Chang, Jason P‐E, Low, Jee‐Keem, Shelat, Vishalkumar G, Huey, Terence C‐W, Dan, Yock‐Young, Kow, Alfred, Shridhar, Iyer, Tan, Poh‐Seng, Junnarkar, Sameer P, Tan, Chee‐Kiat
Publicado 2021

Blood-derived lysophospholipid sustains hepatic phospholipids and fat storage necessary for hepatoprotection in overnutrition

por Chin, Cheen Fei, Galam, Dwight L.A., Gao, Liang, Tan, Bryan C., Wong, Bernice H., Chua, Geok-Lin, Loke, Randy Y.J., Lim, Yen Ching, Wenk, Markus R., Lim, Miao-Shan, Leow, Wei-Qiang, Goh, George B.B., Torta, Federico, Silver, David L.
Publicado 2023

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma

por Jin, Yu, Wong, Ye Shen, Goh, Brian K. P., Chan, Chung Yip, Cheow, Peng Chung, Chow, Pierce K. H., Lim, Tony K. H., Goh, George B. B., Krishnamoorthy, Thinesh Lee, Kumar, Rajneesh, Ng, Tze Pin, Chong, Samuel S., Tan, Hwee Huang, Chung, Alexander Y. F., Ooi, London Lucien P. J., Chang, Jason P. E., Tan, Chee Kiat, Lee, Caroline G. L.
Publicado 2019

Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study

por Anstee, Quentin M., Lucas, Kathryn J., Francque, Sven, Abdelmalek, Manal F., Sanyal, Arun J., Ratziu, Vlad, Gadano, Adrian C., Rinella, Mary, Charlton, Michael, Loomba, Rohit, Mena, Edward, Schattenberg, Jörn M., Noureddin, Mazen, Lazas, Donald, Goh, George B.B., Sarin, Shiv K., Yilmaz, Yusuf, Martic, Miljen, Stringer, Rowan, Kochuparampil, Jossy, Chen, Li, Rodriguez-Araujo, Gerardo, Chng, Elaine, Naoumov, Nikolai V., Brass, Clifford, Pedrosa, Marcos C.
Publicado 2023

Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

por Sanyal, Arun J., Lopez, Patricia, Lawitz, Eric J., Lucas, Kathryn J., Loeffler, Juergen, Kim, Won, Goh, George B. B., Huang, Jee-Fu, Serra, Carla, Andreone, Pietro, Chen, Yi-Cheng, Hsia, Stanley H., Ratziu, Vlad, Aizenberg, Diego, Tobita, Hiroshi, Sheikh, Aasim M., Vierling, John M., Kim, Yoon Jun, Hyogo, Hideyuki, Tai, Dean, Goodman, Zachary, Schaefer, Felicity, Carbarns, Ian R. I., Lamle, Sophie, Martic, Miljen, Naoumov, Nikolai V., Brass, Clifford A.
Publicado 2023